Defining the Optimal FVIII Transgene for Placental Cell-Based Gene Therapy to Treat Hemophilia A
2020 · Molecular Therapy — Methods & Clinical Development · 15 citations
https://doi.org/10.1016/j.omtm.2020.03.001
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
19
Papers
62
Citations
5
h-index
2
i10-index
Martin Rodriguez is an academic researcher from Wake Forest University. The author has contributed to research in topics: Hemophilia Treatment and Research & Neurogenetic and Muscular Disorders Research & Cellular transport and secretion. The author has an h-index of 5, co-authored 17 publications.
ORCID: 0000-0003-4493-0130Click to start Chat